Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026)
Structure Therapeutics' (GPCR) quarterly Prepaid Assets came in at $32.1 million in Q1 2026, up 151.92% year-on-year from $12.7 million in Q1 2025, and up 33.14% quarter-over-quarter from $24.1 million in Q4 2025.
Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026) Analysis & Trends
Structure Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $32.1 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 151.92% year-over-year to $32.1 million in Q1 2026; TTM through Mar 2026 was $32.1 million, a 151.92% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 213.35% from the prior year.
- Prepaid Assets rose to $32.1 million in Q1 2026 per GPCR's latest filing, from $24.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $32.1 million in Q1 2026 and bottomed at $2.2 million in Q4 2022.
- The 5-year median for Prepaid Assets is $9.4 million (2024), against an average of $11.3 million.
- Biggest YoY gain for Prepaid Assets was 213.35% in 2025; the steepest drop was 1.32% in 2025.
- Year by year, Prepaid Assets stood at $2.2 million in 2022, then soared by 179.58% to $6.3 million in 2023, then increased by 22.4% to $7.7 million in 2024, then soared by 213.35% to $24.1 million in 2025, then jumped by 33.14% to $32.1 million in 2026.
- Per Business Quant, the three latest GPCR Prepaid Assets figures stand at $32.1 million (Q1 2026), $24.1 million (Q4 2025), and $15.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Structure Therapeutics | 11.04 Bn | 11.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.09 Mn |
| Dec 31, 2025 | 24.11 Mn |
| Sep 30, 2025 | 14.98 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 12.74 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 30, 2024 | 8.37 Mn |
| Jun 30, 2024 | 10.50 Mn |
| Mar 31, 2024 | 12.91 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 5.29 Mn |
| Dec 31, 2022 | 2.25 Mn |